跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gluclazide SR - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gluclazide SR
Approved
STANDARD
Gluclazide SR
Krka, D.D., Novo Mesto
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4373c72cb457c28e
Company
Krka, D.D., Novo Mesto
Type
Standard
Approval Details
Approval Id
4373c72cb457c28e
Drug Approval Philippines Name
Gluclazide SR
Product Name
Gluclazide SR
Registration Number
DRP-16291
Brand Name
Gluclazide SR
Generic Name
Gliclazide
Dosage Form
Prolonged-Release Tablet
Dosage Strength
30 mg
Manufacturer
Krka, D.D., Novo Mesto
Importer
Ambicare Pharmaceuticals Inc.
Distributor
Ambicare Pharmaceuticals Inc.
Company Detail Path
/organization/krka-d-d-novo-mesto
Issuance Date
28 January 2025
Expiry Date
28 January 2030
Pharmacologic Category
Blood Glucose Lowering Drug
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4373c72cb457c28e
Type
Standard
Back to Philippines FDA Approvals